Literature DB >> 18997809

Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users.

A Aversa1, F Rossi, D Francomano, R Bruzziches, C Bertone, V Santiemma, G Spera.   

Abstract

Aim of the study was to evaluate whether endothelial dysfunction is a marker of erectile dysfunction (ED) in recreational drug abuse. Sixty-four non-consecutive men complaining of ED from at least 3 months were included. All patients underwent detailed history about recreational drug abuse and were then submitted to dynamic penile duplex ultrasound (PDU). According to pharmaco-stimulated peak systolic velocity (PSV) cutoff at 35 cm s(-1), patients were divided into two groups: organic (O; n=30) and non-organic (NO; n=34) ED. All subjects and 7 healthy age-matched subjects as controls, underwent veno-occlusive plethysmography (VOP) for the evaluation of endothelium-dependent dilatation of brachial arteries. Blood pressure, total and free testosterone, prolactin, estradiol, low-density lipoprotein and high-density lipoprotein cholesterol were also evaluated; patients were classified with regard to insulin resistance through the HOMA-IR index. Cannabis smoking was more frequent in O-ED vs NO-ED (78% vs 3%, P<0.001) in the absence of any concomitant risk factor or comorbidity for ED. VOP studies revealed impaired endothelium-dependent vasodilatation in O-ED but not in NO-ED and controls (12+/-6 vs 32+/-4 and 34+/-5 ml min(-1), respectively; P=0.003). Overall patients showed a direct relationship between HOMA-IR and PSV (r(2)=0.47, P<0.0001), which was maintained in men with organic ED (r(2)=0.62, P<0.0001). In cannabis consumers, a direct relationship between HOMA-IR and VOP was also found (r(2)=0.74, P<0.0001). Receiver-operating characteristic (ROC) curve analysis revealed that VOP values below 17.22 ml min(-1) were suggestive for vasculogenic ED. We conclude that early endothelial damage may be induced by chronic cannabis use (and endocannabinoid system activation); insulin resistance may be the hallmark of early endothelial dysfunction and may concur to determine vascular ED in the absence of obesity. Further studies are warranted to establish a direct relationship between cannabis abuse, onset of insulin resistance and development of vascular ED.

Entities:  

Mesh:

Year:  2008        PMID: 18997809     DOI: 10.1038/ijir.2008.43

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  15 in total

Review 1.  Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility.

Authors:  Stefan S du Plessis; Ashok Agarwal; Arun Syriac
Journal:  J Assist Reprod Genet       Date:  2015-08-16       Impact factor: 3.412

2.  Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses.

Authors:  Martin Reriani; Andreas J Flammer; Jing Li; Megha Prasad; Charanjit Rihal; Abhiram Prasad; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-11       Impact factor: 1.439

3.  Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy.

Authors:  Yuefeng Wang; Tian Liu; Peter J Rossi; Deborah Watkins-Bruner; Wayland Hsiao; Sherrie Cooper; Xiaofeng Yang; Ashesh B Jani
Journal:  J Sex Med       Date:  2013-06-06       Impact factor: 3.802

4.  Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Marco Natali; Andrea Lenzi
Journal:  Ther Adv Urol       Date:  2009-10

Review 5.  The effects of cannabis and cannabinoids on the endocrine system.

Authors:  Farah Meah; Michelle Lundholm; Nicholas Emanuele; Hafsa Amjed; Caroline Poku; Lily Agrawal; Mary Ann Emanuele
Journal:  Rev Endocr Metab Disord       Date:  2021-08-30       Impact factor: 9.306

Review 6.  Cannabinoid signalling and effects of cannabis on the male reproductive system.

Authors:  Mauro Maccarrone; Cinzia Rapino; Felice Francavilla; Arcangelo Barbonetti
Journal:  Nat Rev Urol       Date:  2020-11-19       Impact factor: 14.432

7.  Erectile dysfunction and its management in patients with diabetes mellitus.

Authors:  Giuseppe Defeudis; Daniele Gianfrilli; Chiara Di Emidio; Riccardo Pofi; Dario Tuccinardi; Andrea Palermo; Andrea Lenzi; Paolo Pozzilli
Journal:  Rev Endocr Metab Disord       Date:  2015-10-26       Impact factor: 6.514

Review 8.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

9.  Female sexual dysfunction in patients with substance-related disorders.

Authors:  Alessandra Diehl; Rosiane Lopes da Silva; Ronaldo Laranjeira
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

10.  The impact of cannabis use on male sexual function: A 10-year, single-center experience.

Authors:  Benjamin Shiff; Udi Blankstein; Jafar Hussaen; Keith Jarvi; Ethan Grober; Kirk Lo; Katherine Lajkosz; Yonah Krakowsky
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.